Introduction
A fundamental property of human T cells is to provide lifelong immunity against pathogens lasting several decades (1) . The complement of T cells within an individual is heterogeneous and includes naive T cells that develop from thymic precursors, shortlived effector cells, and memory T cells derived from naive T cells following antigen exposure. Maintenance of each of these components for several decades of life is essential to host defense: memory T cells for defense against previously encountered antigens and naive T cells for responses to new antigens. T cell memory is mediated by coordinated action of distinct subsets. Initial pioneering studies classified human memory T cells into effector memory T cells (Tem cells) and central memory T cells (Tcm cells) based on rapid effector function and the expression of lymphoid homing receptors, respectively (2) . More recent studies have identified and characterized a subset of memory T cells resident in nonlymphoid tissues (NLT) that mediate regional immune surveillance against pathogens (3) (4) (5) (6) . Tissue-resident memory T cells (Trm cells) in NLTs outnumber memory CD8 + T cells in lymphoid tissues and represent the primary steady-state surveillance mechanism in NLTs (7) . Both Tcm and Trm cells originate from a common clonal precursor, but following tissue localization, Trm cells maintain a highly regional network and persist over decades of life with apparently little homeostatic turnover (8) (9) (10) . Little is known about the mechanisms that underlie the development, dormancy, and maintenance of these long-lived Trm cells, particularly in humans, and investigation of these areas will have major implications for understanding immune homeostasis within tissues.
Homeostasis in adult tissues is maintained by the differentiation of a small population of adult stem cells. The capacity of T cells for long-term survival, quiescence, clonal differentiation, and self-renewal has elicited comparisons between long-lived postmitotic cells, such as memory T cells and adult stem cells (11) . Indeed, prior studies have shown that murine memory T cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells (HSCs) (12) . Goodell et al. described the ability to efflux lipophilic Hoechst dyes as a distinct property of a subset of HSCs, termed side population (SP) cells, with enhanced regenerative potential (13, 14) . The SP phenotype (i.e., dye efflux) is mediated by the expression of ATP-binding cassette (ABC) transporters (particularly ABCG2 in most HSCs and some adult stem cells), and cells with SP phenotype have been identified in putative stem cells in diverse tissues (15) (16) (17) (18) . ABC transporters efflux diverse substrates, and their expression in stem cells is postulated to protect these cells from xenotoxic, oxidative, and metabolic stress (15, 19) . Human CD8 + memory T cells expressing P-glycoprotein/ ABCB1 were shown to persist following cancer chemotherapy (20) ; however, most human T cells with ABCB1 + phenotype were later shown to be mucosa-associated invariant T (MAIT) cells (21) . We hypothesized that human T cells with SP phenotype may identify a subset with distinct biologic and functional properties. Here, we show that SP phenotype marks a distinct subset of human and Immune surveillance in tissues is mediated by a long-lived subset of tissue-resident memory T cells (Trm cells). A putative subset of tissue-resident long-lived stem cells is characterized by the ability to efflux Hoechst dyes and is referred to as side population (SP) cells. Here, we have characterized a subset of SP T cells (Tsp cells) that exhibit a quiescent (G 0 ) phenotype in humans and mice. Human Trm cells in the gut and BM were enriched in Tsp cells that were predominantly in the G 0 stage of the cell cycle. Moreover, in histone 2B-GFP mice, the 2B-GFP label was retained in Tsp cells, indicative of a slow-cycling phenotype. Human Tsp cells displayed a distinct gene-expression profile that was enriched for genes overexpressed in Trm cells. In mice, proteins encoded by Tsp signature genes, including nuclear receptor subfamily 4 group A member 1 (NR4A1) and ATP-binding cassette (ABC) transporters, influenced the function and differentiation of Trm cells. Responses to adoptive transfer of human Tsp cells into immune-deficient mice and plerixafor therapy suggested that human Tsp cell mobilization could be manipulated as a potential cellular therapy. These data identify a distinct subset of human T cells with a quiescent/ slow-cycling phenotype, propensity for tissue enrichment, and potential to mobilize into circulation, which may be harnessed for adoptive cellular therapy.
ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells Figure 3C ). Pyronin Y staining represents only a snapshot of cycling status. Label retention in doxycycline-inducible (Dox-inducible) histone H2B GFP mice has been utilized to identify quiescent/ slow-cycling populations of stem cells in adult tissues (25, 26) , but to our knowledge, not yet comparably applied for the evaluation of the quiescent compartment of murine memory T cells in vivo. Mice fed with Dox for 2 weeks were infected with LCMV in the presence of Dox for up to 6 weeks after infection, and subsequently, a 5-week chase was performed by removal of Dox treatment ( Figure 3D ). Uniform labeling of CD8 + T cells expressing GFP prior to chase was verified by flow cytometry (Supplemental Figure 3A ). This strategy revealed that the majority of the lymphoid memory CD8 + T cells in the spleen, liver, or BM have undergone cycling and are GFP -with very few GFP label-retaining CD8 + T cells ( Figure 3E ). In contrast, label-retaining CD8 (Figure 3 , F and G). In contrast with murine tissues and human blood, we were unable to detect Tsp cells in murine blood (Supplemental Figure 3C) . Together, these data identify murine T cells. Trm cells in human and murine tissues such as the gut are highly enriched SP T cells (Tsp cells), and these cells particularly mark a Trm subset with quiescent/slow-cycling phenotype. Human Tsp cells share overlapping transcriptional gene-expression programs with Trm cells (10) , including several members of the NR4A orphan nuclear receptor family, also implicated in HSC quiescence (22, 23) . We also show that 2 key signature genes identified in human Tsp cells, ABC transporters and nuclear receptor subfamily 4 group A member 1 (NR4A1), affect the biology of Trm cells. Harnessing the properties of Tsp cells may therefore allow manipulation of tissue-resident memory in humans. Their quiescence, propensity for tissue localization, and potential to mobilize into circulation also make them attractive candidates for adoptive cellular therapies targeting cancer.
Results

Detection of human Tsp cells.
In order to detect human Tsp cells, freshly isolated human T cells from blood, BM, gut, and skin were analyzed for the ability to efflux Hoechst dye. Prior treatment with verapamil prevented dye efflux and was utilized as a control. Tsp cells could be identified in circulating T cells, but were detected at a much higher frequency in the BM, intestinal epithelium, and skin ( Figure + CD8 + T cells were transferred into naive C57BL/6 (B6) mice and analyzed at different time points following LCMV infection. Tsp CD8 + T cells were initially detected in the lymphoid tissues at day 8 following infection, but declined by day 30 (Supplemental Figure 2A) . In contrast, enrichment of Tsp cells was detected in the BM up to 60 days following infection (Supplemental Figure 2A ). Detailed analysis of tissues at 30 days following infection revealed that Tsp cells were enriched within the BM, liver, and the gut, but not the spleen (Supplemental Figure 2B) scripts that formed a core CD8 + Tsp signature ( Figure 4B , Supplemental Figure 4 and Supplemental Table 1 ). MetaCore pathway analysis for G 0 terms revealed that the top Tsp signature-related pathways were metabolic regulation and cell cycle ( Figure 4C ). Similar analysis for CD4 + Tsp cells revealed that the genes overexpressed within CD4 + Tsp cells were highly overlapping with those in CD8 + Tsp cells (data not shown). Several of the genes overexpressed in Tsp cells are associated with Trm cells, and genes comprising the recently described core signature of human skin Trm cells (27) were increased in CD8 + Tsp cells compared with naive, CD8 + Tem, and Tcm counterparts ( Figure 4D ). This core human CD8 + Tsp signature included XCL1, SKIL, SIK1, and several members of nuclear hormone family of transcription factors NR4A1 (also known as NUR77), NR4A2, and NR4A3, which are also over- + Tsp and NSP fractions. Bar graphs represent data from 7-10 mice. Data were compiled from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, by Student's t test. jci.org Volume 126
Number 10 October 2016 Figure 7A ). This was also associated with a greater degree of tissue infiltration (particularly in the liver) and severity score for GVHD (Figure 7 , B and C). Experiments were repeated twice with 3 to 4 mice in each group; graphs represent data from 1 experiment (n = 4 mice). *P < 0.05, **P < 0.01, ***P < 0.001, by Student's t test. subset may reflect the quiescent compartment in Trm cells. It is notable that this is in contrast to most memory T cells in lymphoid tissues, which are typically in G 1 , which permits homeostatic turnover (34, 35) . Diminished homeostatic cycling of Tsp cells was also confirmed based on the label-retaining fraction of Trm cells in histone 2B GFP mice. Label retention in these mice has also been utilized to identify quiescent compartments in other tissues (25) . It is notable that gut Trm cells seem to have a greater proportion of label-retaining cells than memory T cells in lymphoid tissues. These studies therefore suggest that turnover in the Trm compartment may be lower than in Tcm cells. Furthermore, there is heterogeneity relating to the cell cycle even within Trm cells, and the Tsp phenotype specifically marks the label retaining subset of CD8 + Trm cells within tissues. Two gene families enriched in the Tsp core gene-expression signature were ABC transporters and the NR4A family of transcription factors. ABC transporters are directly responsible for the SP phenotype and postulated to help protect stem cells from oxidative and genotoxic stress, although the nature of specific substrates may depend on the specific tissue (19) . It is likely that these transporters may play a similar role in the context of T cells as well. This may be particularly true in the setting of Trm cells at barrier sites such as the gut, wherein they may be needed to actively efflux substrates to keep gut Trm cells in the quiescent state. Indeed, gut Trm cells from transporter-deficient mice had an inflammatory phenotype. Notably, increased IFN-γ production by gut T cells in these mice was restricted to only Trm cells, but not non-Trm cells, consistent with a Trm-specific impact of transporter deficiency.
In addition to ABC transporters, core gene-expression signatures of Tsp cells was also enriched for the NR4A family of transcription factors. These nuclear receptors act as transcription factors to induce or repress gene expression (29) . NR4A1 is activated as a part of early response, related in part to the strength of TCR signaling and implicated in regulating T cell differentiation (28, 36) . Recently, NR4A1 was shown to regulate the expansion and effector functions of murine CD8 + effector T cells (same as Tem cells) through direct repression of IRF4 (37) . Our studies suggest a role for this factor in the biology of murine Trm cells. T cells from Nur77 -/-mice demonstrated reduced capacity to generate Trm cells, indicating that this transcription factor may be important in regulating the generation/ tissue residence of Trm cells. This dependence on NR4A1 is reminiscent of the situation in patrolling monocytes, which express all 3 NR4A genes, but depend only on NR4A1 (38) .
Adoptive transfer of genetically modified T cells, either with chimeric antigen receptors (CAR) or antitumor TCRs is emerging as a promising therapeutic approach in hematologic malignancies (39, 40) . However, most of the clinical success with CAR T cells to date is limited to patients with leukemia, and there is an unmet need to develop approaches to enhance persistence of transferred T cells and enhance their ability to infiltrate NLTs in order to be able to target solid tumors (39) . Our findings that human/murine Tsp cells represent a quiescent T cell subpopulation, with a potential to be enriched in tissues over the long term in vivo and the ability to be mobilized into circulation in humans, suggest that these cells may provide an attractive platform for immunotherapy, particularly for tumors in NLTs and BM.
The finding that human Tsp cells were capable of greater engraftment and tissue infiltration in vivo supported our hypothesis that these may be attractive vehicles to improve adoptive T cell therapy. However, a potential obstacle with clinical application of such a strategy is that most human Tsp cells are restricted to tissues, including the BM. Human HSCs with SP phenotype and long-term repopulation potential can be mobilized from the BM with the CXCR4 antagonist plerixafor. Therefore, we examined whether this strategy can also lead to concurrent mobilization of human Tsp cells in vivo. Injection of plerixafor led to a marked increase in circulating CD8 + Tsp cells within 24 hours, concurrent with mobilization of CD34 + SP + HSCs. Together, these studies demonstrate that mobilization of human CD8 + Tsp cells is possible using routine methodology and, as such, can permit their potential application as a platform for adoptive T cell therapy in humans (Figure 7, D and E) .
In order to further evaluate whether CD8 + Tsp cells could differentiate into Trm cells, we adoptively transferred murine Tsp cells from P14 (Thy 1. 
Discussion
Here we have identified a distinct subset of human/murine slow-cycling T cells that efflux Hoechst dyes and are enriched within a population of T cells that display canonical Trm properties. T cells with a SP phenotype were enriched in tissues such as gut and skin known to be enriched in Trm cells, but were also enriched in the human BM and could even be detected in human blood. Interestingly, even circulating human Tsp cells express core genomic signatures of human Trm cells within tissues. The precise relationship between circulating Tsp cells and classic tissue-based Trm cells needs further study, although the presence of Trm cells with the vascular compartment in some tissues and traffic of T cell subsets to/from tissues is being increasingly appreciated (5, 7, 30) . Recent studies have also emphasized the presence of a quiescent tissue-resident compartment of memory T cells in stromal niches within the BM (31, 32) , which is consistent with these studies.
A unifying property of human/murine Tsp cells in all tissues (as well as those in human blood) was their enrichment in the G 0 phase of the cell cycle, indicating a quiescent/slow-cycling phenotype. In adult stem cells, quiescence is intricately linked to long-term persistence and repopulating ability (33) . Therefore, it is possible that similar biology exists within T cells and the presence of slow-cycling T cells is essential for long-term maintenance of the naive and memory T cell repertoire. Recent studies analyzing human Trm cells suggest that these cells may be stably maintained over decades of life with only minimal turnover and homeostatic proliferation relative to Tcm cells in lymphoid tissues, although prospective studies of human tissues are lacking to date (8 (24) . In brief, cells were incubated in Hoechst 33342 buffer for 1 hour at 37°C. After that, Pyronin Y (5 μg/ml; SigmaAldrich) was added and cells were incubated for an additional 30 minutes. Subsequently, cells were washed with ice-cold buffer and analyzed using BD-LSRII.
Adoptive transfer of human T cells into NSG mice. Human Tsp cells and control T cells were FACS sorted and adoptively transferred via i.v. injection with 50 to 100 × 1,000 T cells/mouse. To reduce the variability in each experiment, 3 replicate mice from each group received the sorted Tsp cells or control T cells from the same donor. Mice were sacrificed at 8 to 10 weeks. Organs such as skin, liver, and small intestine were tested for tissue pathology. Spleen was harvested, and single-cell suspensions were made and stained for FACS to detect human T cell engraftment. , and the diversity of TCR was profiled using high-throughput sequencing of rearranged TCR β loci from genomic DNA by Adaptive Biotechnologies as previously described (43) .
Microarray analysis. RNA from sorted human SP CD4 + and CD8 + T cells was amplified, labeled, and hybridized on the Affymetrix Human Genome U133 Plus 2.0 microarray chips. The data were analyzed with Gene Spring GX12.5 (Agilent Technologies) and Partek Genomics Suite (6.6) software, as previously described (44, 45) . All original microarray data were deposited in the NCBI's Gene Expression Omnibus (GEO GSE85074).
Immunohistochemistry. Four to five mice per group (8 to 12 weeks) were studied in each experiment. Mice were adoptively transferred with Tsp and control T cells. After 4 weeks of transfer, mice were euthanized and organs (skin, liver and small intestine) were examined for GVHD. Briefly, tissue sections prepared from formalin-fixed tissues were used for H&E staining. Severity score generated was based on tissue pathology.
Histone 2BGFP mice. H2B-GFP mice (25) were purchased from the Jackson Laboratory. Six-week-old mice were fed with Dox (Sigma-Aldrich, D9891, 2 mg/ml, supplemented with sucrose at 10 mg/ml) added to the drinking water for 2 to 3 weeks. Mice were then infected with LCMV-Arm and kept on Dox for 5 more weeks. After 8 weeks of Dox treatment, chase was initiated by discontinuing Dox for 5 more weeks. Mice were then euthanized and analyzed for label-retaining cells.
Statistics. A 2-tailed Student's t test was used to compare data between 2 groups. A P value of less than 0.05 was considered significant.
Study approval. Studies in animals were approved by the Animal Care and Use Committee, and human studies were approved by the Human samples. PBMCs from healthy donors were isolated from buffy coats purchased from the New York Blood Center. Gut T cells were obtained from uninvolved intestine in patients undergoing surgery for diverticular disease or gut biopsies. BM aspirates were obtained from patients with cancer undergoing diagnostic BM biopsies. In some patients, blood samples were collected before and after stem cell mobilization protocol with plerixafor.
Isolation of intestinal and skin T cells. PP were first isolated, followed by isolation of IEL and LPL. After removal of PP, intestines were cut longitudinally, and the intestinal contents along with mucus were removed by gentle scraping. The intestines were then cut into small pieces and incubated in PBS buffer containing 1 mM EDTA, 1 mM DTT, and 5% FBS at 37°C in an incubator-shaker at 28 g for 15 minutes. The supernatant was collected to isolate the IELs, while the remaining intestinal pieces were incubated further in LPL/collagenase (1 mg/ml)/DNase (1 U/ml) in PBS solution at 37°C in an incubator-shaker for 10 minutes for the isolation of LPLs. Skin T cells were obtained from human skin following methods described earlier (42) .
Flow cytometry. Single-cell suspensions were made from human and mouse tissues. Cell-surface FACS staining was performed in FACS buffer (PBS + 2% FBS) by incubating cells with fluorochromeconjugated antibodies for 30 minutes on ice in the dark. After staining, the cells were washed with FACS buffer and analyzed with BD LSRII. Intracellular staining was performed using BD reagents following the manufacturer's protocol. Flow cytometry antibodies for human and mouse were purchased from BD, eBioscience and BioLegend. Flow cytometry data were acquired on BD LSRII with Diva software and analyzed with FlowJo 9.7.7 software (Treestar).
The following fluorescently labeled antibodies were used: anti human CD3 (clone UCHT1; BioLegend), anti human CD4 (clone RPA-T4; BD Biosciences), anti human CD8 (clone SK1; BD Biosciences), anti human CD69 (clone FN50; eBiosciences), anti human CD103 (clone B-Ly7; eBiosciences), anti human CD62L (clone DREG-56; eBiosciences), anti human CCR7 (clone G043 H7; BioLegend), anti human CD45RO (clone UCHL1; BD Biosciences), anti human IFN-γ (clone B27; BD Biosciences), anti human CD45RA (clone HI 100; eBiosciences), anti mouse CD4 (clone RM4.5; BD Biosciences), anti mouse CD8 (clone 53-6.7; BD Biosciences), anti mouse CD69 (clone HI.2F3; eBiosciences), anti mouse CD103 (clone 2E7; eBiosciences), anti mouse CD62L (clone MEL-14; eBiosciences), anti mouse CD44 (clone IM7; eBiosciences), anti mouse Thy1.1 (clone OX-7; BD Biosciences), anti mouse CD45.2 (clone 104; eBiosciences), anti mouse CD45.1(clone A20; eBiosciences), anti mouse IFN-γ (clone XMG1.1; BD Biosciences) and anti mouse TCR Vα2 (clone B20.1; BioLegend).
Detection of Tsp cells. Hoechst staining was performed on single-cell suspension of mouse and human cells at 1 to 2 million cells/ml using the method described by Goodell et al. (13) . In brief, cells were
